Key result
Heterozygous BMPR2 gene editing recapitulates human heritable pulmonary arterial hypertension pathology in lambs.
Why the study?
Limited data exist regarding the onset and course of heritable pulmonary arterial hypertension, and etiologies for phenotypic expression in patients with BMPR2 mutations remain unknown.
The creation of a heterozygous BMPR2(+/-) ovine model provides a novel, viable large animal platform for studying heritable pulmonary arterial hypertension and testing preclinical therapeutics.
Rodent BMPR2 models extend mechanistic PAH insights; leaves open human translation pending validation.
Pulmonary Arterial Hypertension (PAH) is a rare vascular disorder characterized by elevated pressure in pulmonary arteries, eventually leading to right ventricular failure. Approximately 50% of pediatric disease and 20% of adult disease can be linked to a genetic mutation, with nearly 70% of these cases involving mutations in the bone morphogenetic protein receptor type 2 ( BMPR2 ) locus. Investigations using rodent models have made significant advances in our understanding of BMPR2 signaling; however, limited data exist regarding the onset and course of PAH, and etiologies for phenotypic expression in these patients remain unknown. In this work, we describe the development of a novel ovine model of heritable PAH. Because homozygous disruption of BMPR2 is embryonic lethal, we developed heterozygous BMPR2 sheep by using a PAM-disrupting synonymous single stranded oligodeoxyribonucleotide alongside a single guide RNA and Cas9 mediated gene editing strategy. The resulting BMPR2 (+/–) lambs demonstrated cardiac and pulmonary vascular pathology that are consistent with BMPR2 mutation-driven PAH observed in humans. Given the genetic and physiological similarities of BMPR2 (+/–) sheep to humans with heritable PAH, this large animal model will serve as a vital platform for mechanistic molecular studies and will provide a much-needed pre-clinical model for extensive treatment evaluations.
No takes yet. Share an insight, caveat, or question.
Datar et al. (2026) studied Pulmonary Arterial Hypertension (n=8). CRISPR/Cas9 gene editing of BMPR2 vs. Wildtype sheep was evaluated on Development of PAH phenotype. Heterozygous BMPR2 gene-edited lambs developed cardiac and pulmonary vascular pathology consistent with human heritable pulmonary arterial hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: